This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1533317507312957v1 23/2/150    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Saddichha, S. Articles by Pandey, V. Search for Related Content PubMed PubMed Citation Articles by Saddichha, S. Articles by Pandey, V. Pubmed/NCBI databases Medline Plus Health Information Alzheimer's Disease Dementia Social Bookmarking                         What's this?

Alzheimer's and Non-Alzheimer's Dementia: A Critical Review of Pharmacological and Nonpharmacological Strategies

^* To whom correspondence should be addressed. E-mail: saddichha{at}gmail.com.

	Abstract

Objective. Dementia is an age-related progressive neurodegenerative disorder afflicting about 5% of the world’s population, and it is expected to grow dramatically in the future keeping in view our ageing society. Currently available medications appear to be able to produce moderate symptomatic benefits but do not to stop disease progression. In this article, the management of the disorder, including the currently available drugs as well as psychosocial strategies, is discussed. Methods. A computerized search on Pubmed from 1980 to 2006 was carried out and all articles evaluated and graded on NICE guidelines. Results and conclusions. Currently evaluated and accepted medications only bring about a reduction in the deteriorating course. A combination of pharmacotherapy and psychosocial management is the need of the hour.

First published on March 10, 2008, doi:10.1177/1533317507312957

American Journal of Alzheimer's Disease and Other Dementias® 2008;23:150.

A more recent version of this article appeared on May 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. E. Lancioni, N. N. Singh, M. F. O'Reilly, J. Sigafoos, M. T. Pangrazio, M. Megna, N. Zonno, M. L. La Martire, K. Pinto,, and M. G. Minervini Persons With Moderate Alzheimer's Disease Improve Activities and Mood via Instruction Technology American Journal of Alzheimer's Disease and Other Dementias, June 1, 2009; 24(3): 246 - 257. [Abstract] [PDF]

				J. E. Marlo, C. M. Niswender, E. L. Days, T. M. Bridges, Y. Xiang, A. L. Rodriguez, J. K. Shirey, A. E. Brady, T. Nalywajko, Q. Luo, et al. Discovery and Characterization of Novel Allosteric Potentiators of M1 Muscarinic Receptors Reveals Multiple Modes of Activity Mol. Pharmacol., March 1, 2009; 75(3): 577 - 588. [Abstract] [Full Text] [PDF]

				G. E. Lancioni, M. L. La Martire, N. N. Singh, M. F. O'Reilly, J. Sigafoos, K. Pinto, and M. G. Minervini Persons With Mild or Moderate Alzheimer's Disease Managing Daily Activities via Verbal Instruction Technology American Journal of Alzheimer's Disease and Other Dementias, January 1, 2009; 23(6): 552 - 562. [Abstract] [PDF]